Cite Filings / DNLI / 0001921094-23-000573
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Denali Therapeutics Inc. · Filed 2023-08-23 · Acc 0001921094-23-000573

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2023-09-15 144 Sale of Securities
  • 2023-08-23 144 Sale of Securities
  • 2023-08-23 144 Sale of Securities
  • 2023-08-23 4 Chief Medical Officer sold 2,478 shares at $22.60 ($56,003)
  • 2023-08-23 4 COFO and Secretary sold 2,478 shares at $22.59 ($55,978)
  • 2023-08-23 4 President and CEO sold 2,309 shares at $22.59 ($52,160)
  • 2023-08-23 4 Director sold 1,419 shares at $22.60 ($32,069)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…